Clinical Trials
29 trialsSTRAP
National Cancer Centre, Singapore
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Pan-MSI-ACSE
UNICANCER
METALLICA
MedSIR
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
University of Sao Paulo
SNIPP
University Health Network, Toronto
EVACEL
Federation Francophone de Cancerologie Digestive
The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma
Peking Union Medical College Hospital
Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Dana-Farber Cancer Institute
Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
Dana-Farber Cancer Institute
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Peking Union Medical College Hospital
MPPGL
Peking Union Medical College Hospital
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
H. Lee Moffitt Cancer Center and Research Institute
TheraSphere for the Treatment of Liver Metastases
Boston Scientific Corporation
A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
Fox Chase Cancer Center
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
Amgen
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
H. Lee Moffitt Cancer Center and Research Institute
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
Eli Lilly and Company
A Study of Axitinib in Advanced Carcinoid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Region Skane
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
131MIBG to Treat Malignant Pheochromocytoma
National Institutes of Health Clinical Center (CC)
EPO906 in Carcinoid and Other Neuroendocrine Tumors
Novartis
SUNLAND
GERCOR - Multidisciplinary Oncology Cooperative Group
Octreotide LAR as Maintenance Treatment for Patients With NEC
Peking University
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
H. Lee Moffitt Cancer Center and Research Institute
Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
H. Lee Moffitt Cancer Center and Research Institute
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Vanderbilt-Ingram Cancer Center
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
National Institutes of Health Clinical Center (CC)